LinkMed: Qiagen Launches Olerup SSP AB's New Test For Detecting Adverse Reactions To HIV-Medicine In The EU

LinkMed's wholly owned subsidiary Olerup SSP AB has developed a new test that detects genetic variations in the Human Leucocyte Antigen (HLA) system that indicate risk for severe adverse reactions to Abacavir in HIV patients. The test is marketed and sold by Qiagen. Experts expect more tests for similar markers in the future.

Add to: del.icio.us | Digg